Foster & Motley »

Vertex Pharmaceuticals Incorporated shares owned by Foster & Motley

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Foster & Motley from 13F filings

Historical chart of Foster & Motley investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Foster & Motley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Foster & Motley

Quarter filed Position value Share count Share price at filing
2024-09-30 $208k 447 465.32
2024-06-30 $216k 460 469.57
2023-06-30 $201k 572 351.40

More positions owned by Foster & Motley

Schwab Fundamental Intl Lg Co ETF Etf (FNDF)
Apple (AAPL)
Schwab International Equity ETF Etf (SCHF)
Hartford Multifactor Developed Markets ETF Etf (RODM)
Janus Henderson Mortgage-Backed ETF Etf (JMBS)
Schwab Fundamental Emerg Mkts Lg Co ETF Etf (FNDE)
Avantis Emerging Markets Equity ETF Etf (AVEM)
Schwab Intermediate-Term U.S. Trsy ETF Etf (SCHR)
Cambria Emerging Shareholder Yield ETF Etf (EYLD)
Microsoft Corporation (MSFT)
Managed Portfolio Ser tortoise nram pi (TPYP)
Vanguard Reit Index ETF Etf (VNQ)
Alphabet Inc Class C cs (GOOG)
Schwab US TIPS ETF Etf (SCHP)
Schwab U.S. REIT ETF Etf (SCHH)

View all positions for Foster & Motley

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
Capital Research Global Investors
FMR
Jpmorgan Chase & Co
Wellington Management Company
Geode Capital Management
Jennison Associates
Alliancebernstein
Loomis, Sayles and
Norges Bank Investment Management
Amundi
Morgan Stanley

View all funds holding Vertex Pharmaceuticals Incorporated